VSNL1 and Alzheimer disease: The study by Babić Leko et al. [48], previously mentioned, showed that As concentrations measured in plasma were significantly and positively associated with levels of certain CSF biomarkers for AD, i.e., VILIP-1 and neurofilament light chain, with the latter being predictive of axonal damage in neurological disorders [118].